Treats active duodenal ulcer. ANDA 208784, held by Teva Pharmaceuticals USA. Lansoprazole.
As of Nov 20, 2026, ANDA 208784 (Lansoprazole), held by Teva Pharmaceuticals USA, was first approved by FDA on Sep 21, 2017, with 6 approved supplements and 0 published complete response letters.
Lansoprazole delayed-release orally disintegrating tablets are a proton pump inhibitor (PPI) indicated for the: Treatment of active duodenal ulcer in adults. Eradication of H. pylori to reduce the risk of duodenal ulcer recurrence in adults. Maintenance of healed duodenal ulcers in adults. Treatment of active benign gastric ulcer in adults. Healing of nonsteroidal anti-inflammatory drugs (NSAID)-associated gastric ulcer in adults. Risk reduction of NSAID-associated gastric ulcer in adults. Treatment of symptomatic gastroesophageal reflux disease (GERD) in adults and pediatric patients 1 year of age and older.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 21, 2017 | Original application | Approved | None posted |
| Lansoprazole15MG · tablet, orally disintegrating, delayed release;oral | Lansoprazole | Rx |
| Lansoprazole30MG · tablet, orally disintegrating, delayed release;oral | Lansoprazole | Rx |
| Jun 30, 2023 | Supplement 1Labeling · Standard review | Approved | None posted |
| Jun 30, 2023 | Supplement 2Labeling · Standard review | Approved | None posted |
| Jun 30, 2023 | Supplement 6Labeling · Standard review | Approved | None posted |
| Jun 30, 2023 | Supplement 7Labeling · Standard review | Approved | None posted |
| Jun 30, 2023 | Supplement 8Labeling · Standard review | Approved | None posted |
| Jun 30, 2023 | Supplement 9Labeling · Standard review | Approved | None posted |
| Sep 21, 2017 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters